Conarium Bioworks

Conarium Bioworks is a biotechnology company specializing in the development of programmable in vivo cell therapies. Utilizing a synthetic biology approach, the company engineers viral vectors and genetic circuits to reprogram cells directly within the patient's body, aiming for high precision and reduced toxicity compared to traditional ex vivo methods. Based in Berkeley, California, Conarium Bioworks focuses on creating next-generation treatments for oncology and rare genetic disorders. The company's platform integrates advanced bioengineering techniques to enable tissue-specific and inducible therapeutic expression. By leveraging the expertise of its founders in molecular biology and gene therapy, Conarium Bioworks aims to provide scalable and effective solutions for complex medical challenges.